112 related articles for article (PubMed ID: 38218249)
1. Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
Dregoesc MI; Țigu AB; Bekkering S; van der Heijden CDCC; Rodwell L; Bolboacă SD; Joosten LAB; Netea MG; Riksen NP; Iancu AC
Int J Cardiol; 2024 Apr; 400():131780. PubMed ID: 38218249
[TBL] [Abstract][Full Text] [Related]
2. Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease. The PHAMOS trial (Prospective Halle Monocytes Study).
Höpfner F; Jacob M; Ulrich C; Russ M; Simm A; Silber RE; Girndt M; Noutsias M; Werdan K; Schlitt A
Hellenic J Cardiol; 2019; 60(5):311-321. PubMed ID: 31055050
[TBL] [Abstract][Full Text] [Related]
3. Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Dregoesc MI; Ţigu AB; Bekkering S; van der Heijden CDCC; Bolboacǎ SD; Joosten LAB; Visseren FLJ; Netea MG; Riksen NP; Iancu AC
Front Cardiovasc Med; 2022; 9():731325. PubMed ID: 35211520
[TBL] [Abstract][Full Text] [Related]
4. Single Cell High Dimensional Analysis of Human Peripheral Blood Mononuclear Cells Reveals Unique Intermediate Monocyte Subsets Associated with Sex Differences in Coronary Artery Disease.
Chatterjee N; Komaravolu RK; Durant CP; Wu R; McSkimming C; Drago F; Kumar S; Valentin-Guillama G; Miller YI; McNamara CA; Ley K; Taylor A; Alimadadi A; Hedrick CC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474140
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
Maiolino G; Rossitto G; Pedon L; Cesari M; Frigo AC; Azzolini M; Plebani M; Rossi GP
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):725-32. PubMed ID: 25614283
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
Newman JD; Anthopolos R; Ruggles KV; Cornwell M; Reynolds HR; Bangalore S; Mavromatis K; Held C; Wallentin L; Kullo IJ; McManus B; Newby LKK; Rosenberg Y; Hochman JS; Maron DJ; Berger JS;
Am Heart J; 2023 Dec; 266():61-73. PubMed ID: 37604357
[TBL] [Abstract][Full Text] [Related]
7. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.
Cappellari R; D'Anna M; Bonora BM; Rigato M; Cignarella A; Avogaro A; Fadini GP
Atherosclerosis; 2017 Nov; 266():95-102. PubMed ID: 29017104
[TBL] [Abstract][Full Text] [Related]
8. Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial.
Foldyna B; Zeleznik R; Eslami P; Mayrhofer T; Scholtz JE; Ferencik M; Bittner DO; Meyersohn NM; Puchner SB; Emami H; Pellikka PA; Aerts HJWL; Douglas PS; Lu MT; Hoffmann U
Eur Radiol; 2021 Aug; 31(8):6200-6210. PubMed ID: 33501599
[TBL] [Abstract][Full Text] [Related]
9. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
[TBL] [Abstract][Full Text] [Related]
10. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease.
Arnold KA; Blair JE; Paul JD; Shah AP; Nathan S; Alenghat FJ
Exp Physiol; 2019 Sep; 104(9):1343-1352. PubMed ID: 31264265
[TBL] [Abstract][Full Text] [Related]
11. Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CT.
Yoo J; Song D; Baek JH; Kim K; Kim J; Song TJ; Lee HS; Choi D; Kim YD; Nam HS; Heo JH
Atherosclerosis; 2017 Oct; 265():7-13. PubMed ID: 28825975
[TBL] [Abstract][Full Text] [Related]
12. Epicardial fat volume, an independent risk factor for major adverse cardiovascular events, had an incremental prognostic value to myocardial perfusion imaging in Chinese populations with suspected or known coronary artery disease with a normal left ventricular ejection fraction.
Yang L; Yu W; Wan P; Wang J; Shao X; Zhang F; Yang X; Chen Y; Li Q; Jiang D; Wang Y; Jiang Q; Wang J; Wang Y
Front Cardiovasc Med; 2023; 10():1261215. PubMed ID: 37849937
[TBL] [Abstract][Full Text] [Related]
13. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
[TBL] [Abstract][Full Text] [Related]
14. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
[TBL] [Abstract][Full Text] [Related]
15. Impact of residual coronary lesions on outcomes of myocardial infarction patients with multi-vessel disease.
Ahmed TAN; Othman AAA; Demitry SR; Elmaghraby KM
BMC Cardiovasc Disord; 2024 Jan; 24(1):68. PubMed ID: 38262995
[TBL] [Abstract][Full Text] [Related]
16. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R
Am Heart J; 2013 Oct; 166(4):654-661.e6. PubMed ID: 24093844
[TBL] [Abstract][Full Text] [Related]
17. Early diastolic strain rate by two-dimensional speckle tracking echocardiography is a predictor of coronary artery disease and cardiovascular events in stable angina pectoris.
Hagemann RA; Hoffmann S; Brainin P; Hagemann CA; Fritz-Hansen T; Olsen FJ; Møgelvang R; Biering-Sørensen T
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1249-1260. PubMed ID: 32405734
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of left ventricular ejection fraction reserve assessed by SPECT G-MPI for major adverse cardiovascular event in patients with coronary artery disease].
Zhou YH; Lu Y; Meng JJ; Mou TT; Bai YJ; Zhang S; Zheng YQ; Deng QJ; Jiao J; Chang Z; Xie XF; Yun MK; Mi HZ; Li X; Zhang XL
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):626-632. PubMed ID: 37312481
[No Abstract] [Full Text] [Related]
19. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
20. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
